Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2020 | 1 |
2021 | 1 |
2023 | 2 |
Search Results
3 results
Results by year
Filters applied: . Clear all
Page 1
Nebulised interferon-β1a (SNG001) in hospitalised COVID-19: SPRINTER phase III study.
ERJ Open Res. 2023 Mar 27;9(2):00605-2022. doi: 10.1183/23120541.00605-2022. eCollection 2023 Mar.
ERJ Open Res. 2023.
PMID: 36994453
Free PMC article.
Feasibility of home administration of nebulised interferon ß-1a (SNG001) for COVID-19: a remote study.
Francis NA, Monk PD, Nuttall J, Oliver T, Simpson C, Brookes JL, Tear VJ, Thompson AG, Batten TN, Mankowski M, Wilkinson TM.
Francis NA, et al. Among authors: batten tn.
BJGP Open. 2023 Sep 19:BJGPO.2023.0089. doi: 10.3399/BJGPO.2023.0089. Online ahead of print.
BJGP Open. 2023.
PMID: 37669805
Free article.
Item in Clipboard
Safety and efficacy of inhaled nebulised interferon beta-1a (SNG001) for treatment of SARS-CoV-2 infection: a randomised, double-blind, placebo-controlled, phase 2 trial.
Monk PD, Marsden RJ, Tear VJ, Brookes J, Batten TN, Mankowski M, Gabbay FJ, Davies DE, Holgate ST, Ho LP, Clark T, Djukanovic R, Wilkinson TMA; Inhaled Interferon Beta COVID-19 Study Group.
Monk PD, et al. Among authors: batten tn.
Lancet Respir Med. 2021 Feb;9(2):196-206. doi: 10.1016/S2213-2600(20)30511-7. Epub 2020 Nov 12.
Lancet Respir Med. 2021.
PMID: 33189161
Free PMC article.
Clinical Trial.
Item in Clipboard
Cite
Cite